Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.38 USD | -2.00% | -10.17% | -42.23% |
05-06 | Oppenheimer Adjusts Relay Therapeutics Price Target to $25 From $33, Maintains Outperform Rating | MT |
05-02 | Earnings Flash (RLAY) RELAY THERAPEUTICS Reports Q1 Revenue $10M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.23% | 864M | |
+25.00% | 46.71B | |
+48.83% | 41.8B | |
-1.23% | 41.52B | |
-5.86% | 29.55B | |
+10.34% | 25.78B | |
-20.80% | 19.26B | |
+2.05% | 12.14B | |
-3.24% | 12.08B | |
+28.52% | 11.98B |
- Stock Market
- Equities
- RLAY Stock
- News Relay Therapeutics, Inc.
- Transcript : Relay Therapeutics, Inc. - Special Call